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Abstract 
Background: Celiac disease (CD) and eosinophilic esophagitis (EoE) are distinct diseases of the gastrointestinal tract 
with specific clinico-pathological characteristics. Recent studies have found higher rates of EoE in patients with CD 
than in the general population. Our aim was to estimate the incidence of EoE among children who were diagnosed 
with CD over a 42-month period.
Methods: The study included patients diagnosed with CD based on endoscopy and histopathological findings 
between January 2010 and June 2013. Histopathology reports of esophageal biopsies were reviewed to identify all 
cases of EoE. The patients’ presenting symptoms, laboratory evaluations, endoscopic and histopathological findings, 
treatments, and follow-ups were analysed.
Results: Fifty-six patients with CD were identified, of whom six (10.7%) were diagnosed with both CD and EoE. Four 
of these patients presented with abdominal pain and diarrhea, two presented with failure to thrive, and three pre-
sented with food allergies. Endoscopic and histopathological changes typical of EoE were observed in all six patients. 
During follow-up, two patients showed significant improvement with the gluten-free diet and a proton-pump inhibi-
tor (PPI). Two patients improved with the elimination diet and two patients were treated with topical corticosteroid 
therapy. Endoscopic appearance was normal in all children on follow-up endoscopy after treatment. Biopsy samples 
also showed resolution of the histologic features of EoE in all of the children.
Conclusion: The incidence of EoE in our cohort of children with CD was 10.7%, which is higher than what has been 
reported for the general population. In all children undergoing upper gastrointestinal endoscopy for suspected CD, 
coexistence of EoE should be considered.
© 2015 Dharmaraj et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Eosinophilic esophagitis (EoE) and celiac disease (CD) 
are considered distinct immunologic diseases of the gas-
trointestinal tract with specific clinico-pathological char-
acteristics. EoE is an emerging, chronic, inflammatory 
disorder of the esophagus. The incidence of EoE varies 
from 0.7 to 10 per 100,000 per person-year, and the preva-
lence ranges from 0.2 to 43 per 100,000 [1]. The incidence 
of EoE seems to be increasing in both adults and chil-
dren, though it is still unclear whether this is a genuine 
phenomenon or attributable to an increasing awareness 
and detection of the disease. EoE presents with a range of 
diverse clinical symptoms. Symptoms in children vary by 
age with infants and young children typically presenting 
with feeding difficulties, reflux and failure to thrive. Vom-
iting, abdominal pain and regurgitation start to become 
apparent in school aged children and it is not until early 
adolescent and teenage years that children present with 
dysphagia and food impaction. Adults typically present 
with symptoms in the third or fourth decade of life, with 
the predominant symptoms being dysphagia, heart burn, 
food impaction and strictures. Diagnosis of EoE is based 
on the presence of symptoms in conjunction with finding 
of more than 15 eosinophils per high power field (HPF) 
in esophageal mucosal biopsy specimens, along with the 
exclusion of other diseases that cause esophageal eosino-
philia [2]. The current diagnostic recommendations for 
EoE are that gastroesophageal reflux disease (GERD) be 
excluded by performing upper gastrointestinal endoscopy 
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and biopsy while receiving proton-pump inhibitor (PPI) 
monotherapy. Although GERD was initially thought to 
cause only mild esophageal eosinophilia (<7 eosinophils/
HPF), recent reports have shown that severe esophageal 
eosinophilia occurs and may resolve with acid-suppression 
monotherapy using PPI. The 2011 EoE consensus recom-
mendations have utilized the term proton-pump inhibitor-
responsive esophageal eosinophilia (PPI-REE) to describe 
this clinical and histological phenomenon [3]. However, 
the pathogenesis of this PPI-REE remains unclear. Stud-
ies from animal models and patients have suggested that 
EoE shares a clinical link with other atopic diseases and 
is caused by immune dysregulation secondary to allergic 
sensitization to dietary or aeroallergens. It is dominated 
by T-helper lymphocyte type 2 mediated eosinophil-pre-
dominant inflammation, with key contributions from mast 
cells, basophils, epithelial cells, and dendritic cells [4].
On the other hand, CD is an immune mediated dis-
ease of the small intestine, induced by the ingestion 
of gluten. This enteropathy may appear at any age and 
is characterized by a wide variety of clinical signs and 
symptoms. Among them, gastrointestinal presentations 
include chronic diarrhea, abdominal pain, weight loss, 
or failure to thrive in children; but extra-intestinal mani-
festations are also common [5]. CD affects roughly 1% 
of children, although many cases remain undiagnosed. 
Suspicion of CD should lead to antibody screening tests, 
and positive results should be followed by an intestinal 
biopsy for a definitive diagnosis [6]. Patients with CD are 
known to be at a higher risk for coexisting autoimmune 
diseases, including type 1 diabetes mellitus and autoim-
mune thyroiditis, but their risk of developing atopic dis-
eases remains unclear [7, 8]. The only treatment currently 
available for CD is strict adherence to a gluten-free diet 
for life. Diagnosed, but untreated CD is associated with a 
significant increase in morbidity and mortality [9].
Recent case reports and cohort studies have suggested 
an association between CD and EoE in pediatric popu-
lations [10–15]. All the studies have used retrospectively 
assembled data or hospital admissions, however, which 
may have led to a bias in the results. Over a period of 
42  months, we aimed to estimate the incidence of EoE 




This is a prospective study that was conducted in the 
Pediatric Gastroenterology Clinic at St. John Provi-
dence Children’s Hospital, a tertiary referral center for 
the southeast Michigan community, upon approval by 
the St. John Hospital and Medical Center Institutional 
Review Board. Because this was an observational study, 
the institutional review board waived the requirement 
for informed consent. All pediatric patients with histo-
logically confirmed CD who also had concurrent esopha-
geal biopsies between January 2010 and June 2013 were 
included. Patients with inflammatory bowel disease were 
excluded from the study. Data on the following were col-
lected during initial visit: age at diagnosis; gender; race; 
duration of symptoms; presenting symptoms; allergies; 
medications; and laboratory evaluations.
Esophagogastroduodenoscopy and histology
All patients underwent upper gastrointestinal endos-
copy using pediatric fiberoptic gastroscope at St. John 
Providence Children’s Hospital by an experienced team 
of pediatric gastroenterologists. Endoscopic findings in 
esophagus, stomach and duodenum were documented. 
Endoscopic features required for a diagnosis of EoE 
included esophageal mucosal furrowing, erythema, exu-
dates, decreased vascular markings or circumferential 
rings. For the histopathological examination, four biop-
sies from the duodenum, two biopsies from the stomach, 
and three biopsies from both the proximal and distal 
esophagus were obtained with endoscopic biopsy for-
ceps. The biopsy specimens were fixed immediately in 
formalin solutions for 4–6  h at room temperature and 
were routinely processed for conventional histological 
evaluation. All biopsies were reviewed with gastrointesti-
nal pathologists with extensive experience with pediatric 
gastrointestinal pathology. Diagnosis of CD was based on 
the Modified Marsh classification of histologic findings. 
Marsh stage 1 biopsies are less specific and only consid-
ered to represent CD in the setting of positive (>10.0 U/
mL) human recombinant tissue transglutaminase anti-
body IgA assay in symptomatic patients. EoE was diag-
nosed based on the presence of typical symptoms and an 
esophageal biopsy demonstrating greater than 15 eosino-
phils per HPF in the proximal and distal esophagus [2]. 
All patients with CD and EoE were referred to allergists 
for evaluation of food and environmental allergen sensi-
tivities by skin prick test.
Statistical analysis
All data is presented as mean ± standard deviation (SD). 
Student t test was used to compare the clinical character-
istics in two groups of our study patients—those with CD 
and those with both CD and EoE. All statistical analyses 
were carried out using Statistical package for social sci-
ence (SPSS) for Windows, version 18 (SPSS Inc., Chicago, 
IL, USA). Statistical significance was defined by P ≤ 0.05.
Results
A total of 56 children were enrolled in the center during the 
study period, of whom fifty were diagnosed with CD. Six 
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patients were diagnosed with both CD and EoE (Figure 1). 
The incidence of EoE in our study population was 10.7%. 
Table  1 outlines the characteristics and clinical presenta-
tion of the six patients identified with EoE and CD.
The mean age of presentation in patients with both 
CD and EoE was 11.6  ±  1.6  years (mean  ±  SD). The 
mean duration of symptoms was 15.9  ±  2.2  months 
(mean ±  SD). The majority of patients (5/6) were male. 
Most of our patients (4/6) presented with abdominal 
pain and diarrhea. Two patients reported failure to thrive 
alone, and dysphagia occurred in one patient. Food aller-
gies were demonstrated in three patients based on skin 
prick testing. An abnormal celiac screening test (positive 
for human recombinant tissue transglutaminase antibody 
IgA) was seen in all six patients, and none was IgA defi-
cient. All six patients were initially treated with empiric 
oral PPI (omeprazole) for GERD by primary care phy-
sicians at the time of study enrollment and biopsy. The 
median dose of omeprazole was 30 mg (range 20–40 mg) 
and median duration of use was 10  weeks (range 
6–20 weeks).
The endoscopic and histopathological findings are 
described in Table  2. A variety of endoscopic findings 
were noted in all six patients. Endoscopic examination 
of the duodenum found mucosal changes that were sug-
gestive of CD in four patients. Esophageal biopsies were 
taken from the proximal and distal esophagus in all six 
patients. None of the biopsy specimens from the stomach 
or duodenum showed significant eosinophilic infiltration. 
Esophageal fungal stain was negative, and there was no 
evidence of Helicobacter pylori histologically, or upon 
staining, in any patient. Most of the patients (4/6) with 
CD had a Marsh score of 3b, and two patients had a score 
of 2.
Gluten-free diet was advised in all six patients, along 
with a PPI. PPI was continued after the diagnosis of EoE 
as a cotherapy to alleviate symptoms related to secondary 
GERD, which might be present with EoE [16]. Patients 
were evaluated again in the GI clinic within a 2–3-month 
period and a follow up endoscopy was performed in all 
subjects. We defined treatment response as resolution 
of endoscopic and histologic changes (<7 eosinophils 
per HPF with regression of basal layer hyperplasia and 
papillary lengthening) on follow-up endoscopy. Two 
patients (#3, #4) showed significant improvement in 
symptoms and resolution of endoscopic and histological 
changes with the gluten-free diet and a PPI. Three other 
Figure 1 Distribution of patients. A total of 56 children were diag-
nosed with CD during the study period. Six patients were diagnosed 
with both CD and EoE. CD celiac disease, EoE eosinophilic esophagitis.
Table 1 The characteristics and clinical presentation of children with CD and EoE
CD celiac disease, EoE eosinophilic esophagitis, TTG IgA anti-tissue transglutaminase antibody Ig.
Pt. no Symptoms Personal history Family history TTG IgA (U/mL)
1 Abdominal pain, diarrhea Food allergies, type 1 diabetes mellitus Type 1 diabetes mellitus >300
2 Failure to thrive Food allergies eczema, asthma CD 112
3 Abdominal pain, diarrhea, increased flatulence – – 300
4 Abdominal pain, diarrhea, headache, mouth ulcers – CD >300
5 Failure to thrive – – >300
6 Abdominal pain, diarrhea, dysphagia Food allergies – 180
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patients (#1, #2, #6) were also treated with an elimina-
tion diet following confirmed food allergies. Two of these 
three patients (#1, #2) showed remarkable improvement 
in symptoms with resolution of eosinophilia at repeat 
esophageal biopsies on follow-up. Patient #6 didn’t 
improve and was managed with topical corticosteroid 
therapy [fluticasone dipropionate MDI (220  mcg), two 
puffs swallowed twice a day]. At the 6-month follow-up, 
the patient showed improvement in symptoms, and a 
repeat endoscopy revealed significant reduction in eosin-
ophilic infiltration. One patient (#5) was also treated 
with topical corticosteroid therapy at the time of diagno-
sis. During follow-up, the patient showed resolution of 
eosinophilic infiltration at repeat esophageal biopsies, as 
well as clinical improvement.
We also compared the clinical characteristics in two 
groups of our study patients—those with CD and those 
with both CD and EoE. The results are given in Table 3. 
We noticed a significant difference in regards to gen-
der and food allergies. Patients with CD and EoE were 
also noticed to have higher levels of TTG IgA in serum, 
although it didn’t reach statistical significance. Patients 
with CD and EoE were also noted to have higher Marsh 
scores and significant endoscopic changes in esophagus.
Discussion
Over the past few decades, both the incidence and preva-
lence of EoE in children increased significantly, which 
may be due to a genuine increase in incidence, greater 
recognition of EoE, or a higher use of diagnostic EGDs 
in children with the wide variety of symptoms sugges-
tive of EoE [17–21]. Studies have shown that EoE can be 
associated with various other conditions including CD. 
The coexistence of EoE and CD in the same patient was 
first described in 2007 by Verzegnassi et  al. [10], who 
observed that patients with EoE seemed more likely to 
develop CD than did the general population. Since then, 
a number of cases have been described in Italy by Qua-
glietta et  al. [11], who found that in patients diagnosed 
with EoE, 35.2% had both diseases. This prevalence was 
lower (3.2%) in an Australian report of 221 children with 
CD, all of whom had undergone esophageal biopsies [12]. 
Leslie et  al. [13] reported the prevalence of EoE to be 
8.2% among 121 children with CD who had concurrent 
esophageal biopsies. A recent retrospective review also 
published increased incidence of EoE in both children 
and adults with CD compared to the general population 
[14]. The incidence of EoE in our cohort of children with 
CD was 10.7%.
The pathogenetic mechanism underlying the simulta-
neous presence of these conditions remains unknown. 
CD is an autoimmune enteropathy, thought to be medi-
ated by Th1-immune response against ingested gluten-
derived peptides in genetically susceptible individuals 
[22]. EoE, however, has been shown to be a Th2-mediated 
disease that is characterized by dense and isolated esoph-
ageal eosinophilia, which cannot be attributed to GERD 
or other causes. The underlying mechanisms of EoE 
remain unclear, but it is thought to be an immediate and 
delayed hypersensitivity disordered response to inhaled 
Table 2 Endoscopic, histopathological findings and treatment of children with CD and EoE
CD celiac disease, EoE eosinophilic esophagitis, IEEo intraepithelial esophageal count, PPI proton-pump inhibitor, EGD esophagogastroduodenoscopy.
Pt. no Endoscopy findings at diagnosis Histopathological findings  
at diagnosis
Treatment IEEo at 
followup
Total no of EGD 
performed
Esophagus Stomach Duodenum IEEo Stomach Duodenum 
(Marsh score)
1 Linear furrow-
ing and white 
exudates
Normal Scalloping 24 Non specific 
gastritis












ing and white 
exudates
Normal Scalloping >50 Normal 3b Gluten-free diet, 
PPI
0 2
5 Linear furrowing 
and circumfer-
ential rings
Normal Scalloping >50 Non specific 
gastritis
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or ingested allergens. Interactions between genetic and 
environmental factors appear to be important. Famil-
ial patterns, usually male predominance (in the current 
study) and association with atopic conditions, have been 
described in previous studies [23].
It is unknown if gluten is the inciting antigen for esoph-
ageal eosinophilia in patients with CD. Studies have 
shown that a gluten-free diet alone failed to improve 
the manifestations of EoE in children with CD and EoE, 
suggesting involvement of antigens other than gluten. 
According to one theory [24], increased intestinal per-
meability secondary to CD may facilitate the exposure 
of the intestinal immune system to various antigens. 
Subsequent hypersensitivity reactions in genetically 
predisposed individuals at various body sites, includ-
ing the esophagus, may lead to allergen sensitization, 
eosinophilic infiltration, and EoE. In our study, children 
with CD and EoE had higher serum levels of tissue trans-
glutaminase IgA and moderate to severe villous atro-
phy in duodenal biopsies. Based on these findings, we 
can conclude that children with severe mucosal damage 
secondary to CD are at a higher risk of developing EoE, 
secondary to increased exposure to various antigens and 
allergens.
Immunologically, CD is a Th1-mediated disease, and 
EoE is a Th2-mediated immune response. The possibility 
of co-existing Th1 and Th2 diseases is still under debate. 
However, molecular studies have shown that autoim-
mune and atopic diseases share risk factors that increase 
the propensity of the immune system to generate both 
Th1 and Th2 mediated inappropriate responses to non-
pathological antigens. These findings seem to suggest 
Table 3 Comparison of clinical characteristics between CD alone vs. with CD and EoE
CD celiac disease, EoE eosinophilic esophagitis, TTG IgA anti-tissue transglutaminase antibody IgA, SD standard deviation.
Clinical characteristics CD (n = 50) mean ± SD or n (%) CD and EoE (n = 6) mean ± SD or n (%) P value
Demographics
 Age at diagnosis (years) 10.5 ± 4.3 11.6 ± 1.6 0.536
 Gender
  Male/Female 17 (34)/33 (66) 5 (83)/1 (17) 0.030
 Race
  Caucasian/Other 48 (96)/2 (4) 5 (83)/1 (17) 0.293
  Duration of symptoms (months) 13.8 ± 14.6 15.9 ± 12.2 0.738
 History of allergies
  Asthma 2 (4) 1 (17) 0.293
  Food allergy 8 (16) 4 (67) 0.016
 Presenting symptoms
  Abdominal pain 27 (54) 4 (67) 0.682
  Dysphagia 0 (0) 1 (17) 0.107
  Failure to thrive 12 (24) 3 (50) 0.326
  Diarrhea/Constipation 18 (36) 0 (0) 0.162
 Endoscopy findings
  Normal esophagus 50 (100) 0 (0) <0.0005
  Ringed esophagus 0 (0) 1 (17) 0.035
  Esophageal mucosal furrows 0 (0) 5 (85) 0.0005
  White plaques in esophagus 0 (0) 4 (67) 0.001
  Normal duodenum 24 (48) 4 (67) 0.669
  Scalloping duodenum 25 (50) 2 (33) 0.671
 Histopathological findings
  TTG IgA (U/mL) 164.4 ± 129.2 248.7 ± 82.4 0.058
  Esophageal eosinophilia 1.1 ± 2.4 42 ± 20 0.0001
 Marsh score –
  1 8 (16) 0 (0)
  2 8 (16) 2 (33)
  3a 16 (32) 0 (0)
  3b 18 (36) 4 (67)
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more than a casual association between CD and EoE and 
a more generalized defect of immune regulation [25–27].
Among adults with eosinophilic esophagitis, the pre-
dominant symptoms are dysphagia and food impaction. In 
a population-based epidemiologic study, these were also 
identified as the primary symptoms among older children 
and adolescents. Conversely, younger children and infants 
had different and vaguer symptoms, including vomiting 
and abdominal pain, and typically did not present with food 
impaction [28, 29]. Most of our patients did not present 
with symptoms suggestive of EoE; however, a significant 
proportion of patients were noticed to have food aller-
gies. Regardless of their presenting symptoms, endoscopic 
changes were demonstrated in most of the patients, and 
microscopic changes were noticed in all of our patients.
It is unknown whether EoE in patients with CD 
responds to a gluten-free diet alone. Two patients in our 
study showed clinical improvement in symptoms with the 
gluten-free diet and a PPI, and this was confirmed by an 
upper endoscopy and histopathological examination. It is 
possible that these patients could have had PPI-REE; how-
ever, both patients received an adequate course of PPI at 
the time of endoscopy and biopsy. The lack of a clinico-
pathologic response to PPI treatment in these patients 
adherent to the treatment regimen with compatible symp-
toms of EoE and esophageal eosinophilia is consistent with 
the diagnosis of EoE. The rest of our patients required 
other forms of treatment including an elimination diet and 
oral corticosteroid treatment. Recent studies have shown 
that a gluten-free diet did not appear to induce remission 
of coexistent endoscopic and histopathological features 
of EoE in patients with CD. However, the sample size was 
smaller in this series, and these findings need to be con-
firmed with larger samples of patients [15].
We acknowledge several limitations of the present 
study. First, none of our patients had esophageal pH 
monitoring or impedance testing to rule out GERD as 
the cause of symptoms. Second, we studied compara-
tively few patients with CD and EoE, and the study may 
not adequately compare the clinical characteristics with 
the CD population of children. Third, there was no pro-
longed follow-up or outcome in our patients with CD 
and EoE, so it is unclear whether the various treatments 
used for EoE altered the natural history of this disease.
Conclusion
Our study suggests that the incidence of EoE in our pop-
ulation of children with CD was 10.7%, which is higher 
than the previous reports. Our study confirms similar 
findings from various retrospective reviews—a higher 
than expected incidence of EoE compared with general 
population. We emphasize the importance of performing 
routine esophageal biopsies when investigating for CD, 
irrespective of the presenting symptoms and appearance 
of the esophageal mucosa at endoscopy. More prospec-
tive research is needed to determine the effect of various 
treatment modalities on the outcome of EoE.
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